The U.S. CBD consumer health market size is estimated to be USD 7.81 billion in 2023 and is projected to grow at a CAGR of 14.79% from 2024 to 2033, reaching approximately USD 31.11 billion by 2033.
SCOTTSDALE, AZ / ACCESSWIRE / September 26, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), a leading innovator in the CBD and wellness industry, is proud to announce an astounding revenue increase of 1405.46% since February 2024. This exceptional growth highlights the company's successful strategic initiatives and growing market demand for premium CBD products.
“This important milestone reflects our commitment to innovation, quality and expanding our market reach,” said Lisa Nelson, president and CEO of CBD Life Sciences. “Our team's focus on developing high-quality products and building valuable partnerships has driven this growth, and we are confident we can maintain this momentum as we continue to expand our reach.”
Key drivers of growth
CBD Life Sciences Inc. attributes this impressive growth to several key factors, including the launch of Mellow Mornings nano CBD coffee creamer, the introduction of CBDL products into Walmart Marketplace, and strategic agreements such as memoranda of understanding (MOUs) with cannabis retailers as the company gears up for further expansion into new markets.
Product Innovation and Market Expansion
The company is a pioneer in leveraging advanced nanotechnology to enhance the bioavailability and efficacy of CBD products, offering consumers superior health and wellness options. Innovative products such as Mellow Morning Coffee Creamer and a newly developed dietary supplement powder with a unique blend of Ganoderma lucidum extract, Lion's Mine extract and Ashwagandha root extract have been well received by a growing customer base.
Future outlook
Looking ahead, CBD Life Sciences Inc. is well positioned to continue its upward trajectory. The company is actively exploring new market opportunities and collaborating with prominent athletes, brands, and influencers to further grow its brand presence.
“We are excited about the progress we've made since February and are committed to maintaining this momentum,” Nelson added. “We continue to innovate and expand our product portfolio while remaining focused on delivering exceptional value to our customers and shareholders.”
To learn more about CBD Life Sciences Inc. and its innovative products, please visit www.thecbdvault.com.
About CBD Life Sciences Inc.
CBD Life Sciences Inc. (OTC PINK:CBDL) is a leading CBD and wellness company focused on improving lives through high-quality, scientifically formulated products. With a diverse portfolio that includes CBD tinctures, topicals, edibles and more, CBD Life Sciences Inc. is committed to improving the health of its customers by providing safe and effective solutions.
Follow us on social media for the latest updates.
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Inquiries: (email protected)
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in the forward-looking statements and are subject to risks and uncertainties. Please see CBD Life Sciences, Inc.'s filings with the OTC Markets, which describe certain factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release contains forward-looking statements that reflect management's current expectations based on certain assumptions. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. These factors include general global economic conditions, general industry and market conditions, sector changes and growth rates, uncertainty as to whether our strategy and business plans will generate the expected benefits, increased competition, availability and cost of capital, our ability to identify, develop and achieve commercial success, the level of expenditures required to maintain and improve the quality of our services, changes in the economy, laws and regulations, including codes and standards, intellectual property rights, tax matters, or other issues that are not anticipated, our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements regarding its ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
contact address:
Lisa Nelson
CEO
(email address protected)
4802091720
Related images
Source: CBD Life Sciences, Inc.
